Lung function and symptom recovery in chronic obstructive pulmonary disease with pneumonic and non-pneumonic exacerbations

References

• Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur Respir J. 2023;61(4):2300239. doi:10.1183/13993003.00239-2023.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi:10.1136/thorax.57.10.847.
   PubMed Web of Science ®Google Scholar
• Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med. 2007;101(6):1305–1312. doi:10.1016/j.rmed.2006.10.012.
   PubMed Web of Science ®Google Scholar
• Criner GJ, Bourbeau J, Diekemper RL, et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015;147(4):894–942. doi:10.1378/chest.14-1676.
   PubMed Web of Science ®Google Scholar
• Foo J, Landis SH, Maskell J, et al. Continuing to confront COPD international patient survey: economic impact of COPD in 12 countries. PLoS One. 2016;11(4):e0152618. doi:10.1371/journal.pone.0152618.
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Bhutani M, Hernandez P, et al. 2023 Canadian thoracic society guideline on pharmacotherapy in patients with stable COPD. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. 2023;7(4):173–191. doi:10.1080/24745332.2023.2231451.
   Web of Science ®Google Scholar
• Mittmann N, Kuramoto L, Seung SJ, Haddon JM, Bradley-Kennedy C, FitzGerald JM. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med. 2008;102(3):413–421. doi:10.1016/j.rmed.2007.10.010.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-196.
   PubMed Web of Science ®Google Scholar
• Seemungal TAR, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;161(5):1608–1613. doi:10.1164/ajrccm.161.5.9908022.
   Web of Science ®Google Scholar
• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-8.
   PubMed Web of Science ®Google Scholar
• Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. European Respiratory Journal, Supplement. 2003;21(Suppl. 41):46s–53s. doi:10.1183/09031936.03.00078002.
   Google Scholar
• Celli BR, Fabbri LM, Aaron SD, et al. An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: The Rome proposal. Am J Respir Crit Care Med. 2021;204(11):1251–1258. doi:10.1164/rccm.202108-1819PP.
   PubMed Web of Science ®Google Scholar
• Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respir Crit Care Med. 2019;200(7):E45–E67. doi:10.1164/rccm.201908-1581ST.
   PubMed Web of Science ®Google Scholar
• Metlay JP, Kapoor WN, Fine MJ. Does this patient have community acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA. 1997;278(17):1440–1445.
   PubMed Web of Science ®Google Scholar
• Müllerova H, Chigbo C, Hagan GW, et al. The natural history of community-acquired pneumonia in COPD patients: a population database analysis. Respir Med. 2012;106(8):1124–1133. doi:10.1016/j.rmed.2012.04.008.
   PubMed Web of Science ®Google Scholar
• Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013;68(11):1057–1065. doi:10.1136/thoraxjnl-2013-204282.
   PubMed Web of Science ®Google Scholar
• Huerta A, Crisafulli E, Menéndez R, et al. Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics. Chest. 2013;144(4):1134–1142. doi:10.1378/chest.13-0488.
   PubMed Web of Science ®Google Scholar
• Boixeda R, Bacca S, Elias L, et al. Pneumonia as comorbidity in chronic obstructive pulmonary disease (COPD). Differences between acute exacerbation of COPD and pneumonia in patients with COPD. Arch Bronconeumol. 2014;50(12):514–520. doi:10.1016/j.arbr.2014.10.006.
   PubMed Web of Science ®Google Scholar
• Lieberman D, Lieberman D, Gelfer Y, et al. Pneumonic vs nonpneumonic acute exacerbations of COPD. Chest. 2002;122(4):1264–1270. doi:10.1378/chest.122.4.1264.
   PubMed Web of Science ®Google Scholar
• Myint PK, Lowe D, Stone RA, Buckingham RJ, Roberts CM. UK national COPD resources and outcomes project 2008: patients with chronic obstructive pulmonary disease exacerbations who present with radiological pneumonia have worse outcome compared to those with non-pneumonic chronic obstructive pulmonary disease exacerbations. Respiration. 2011;82(4):320–327. doi:10.1159/000327203.
   PubMed Web of Science ®Google Scholar
• Andreassen SL, Liaaen ED, Stenfors N, Henriksen AH. Impact of pneumonia on hospitalizations due to acute exacerbations of COPD. Clinical Respiratory J. 2014;8(1):93–99. doi:10.1111/crj.12043.
   PubMed Web of Science ®Google Scholar
• Saleh A, López-Campos JL, Hartl S, Pozo-Rodríguez F, Roberts CM. The effect of incidental consolidation on management and outcomes in COPD exacerbations: data from the European COPD audit. PLoS One. 2015;10(7):e0134004. doi:10.1371/journal.pone.0134004.
   PubMed Web of Science ®Google Scholar
• Søgaard M, Madsen M, Løkke A, Hilberg O, Sørensen HT, Thomsen RW. Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia. Int J COPD. 2016;11(1):455–465. doi:10.2147/COPD.S96179.
   Google Scholar
• Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in Dyspnea and disease-specific quality of life following an acute COPD exacerbation. CHEST. 2002;121(3):688–696. doi:10.1378/chest.121.3.688.
   PubMed Web of Science ®Google Scholar
• Lambert J, Lilly E, et al. A macro for getting more out of your ROC curve. Paper Presentation SAS Global Forum. San Antonio, Texas. 2008; Paper 231.
   Google Scholar